Navigation Links
RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
Date:7/5/2012

LAKE FOREST, Ill., July 5, 2012 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Renaissance Acquisition Holdings, LLC ("Renaissance"), has acquired DPT Laboratories Inc. ("DPT").  DPT is a leading pharmaceutical contract development and manufacturing organization with facilities in San Antonio, TX and Lakewood, NJ. As part of the transaction, the current shareholders of DPT will maintain a meaningful equity stake in the combined business.

"Renaissance is excited by the opportunity to further invest in the continued growth and success of DPT," said Pierre Frechette, President and CEO of Renaissance.  "We are committed to supporting DPT's leading market position in semi-solid contract manufacturing and development as well as their emerging business in sterile manufacturing and specialty products." 

"RoundTable and Renaissance are ideal partners for DPT," said John Feik, President and COO of DPT's parent company, DFB Pharmaceuticals, Inc. ("DFB"). "RoundTable's track record of building strong, successful businesses combined with their unique capabilities in this industry truly differentiates them."  Paul Dorman, Chairman and CEO of DFB, added "RoundTable's depth of experience gave us confidence to work exclusively with them to execute on the strategic plan that will drive accelerated growth at DPT." The existing DPT management team will continue to run day-to-day operations at DPT while assuming additional responsibilities within Renaissance.

"Renaissance's acquisition of DPT is an important milestone in RoundTable's strategy to build new pharmaceutical platforms," stated Lester B. Knight, Chairman of Renaissance and Founding Partner and Co-Chairman of RoundTable.  "We continue to be enthusiastic about the opportunities in this important market and look forward to partnering with the DPT management team to build on their success and accelerate the growth of their business."

To finance the acquisition of DPT and further growth opportunities, RoundTable facilitated the successful completion of new senior credit facilities and a private placement of senior subordinated notes.  The senior credit facilities were led by GE Commercial Finance Healthcare Financial Services as Administrative Agent and Co-Lead Arranger, and included PNC Bank National Association as Co-Lead Arranger and Syndication Agent.  DPT's senior subordinated notes were acquired by RoundTable Capital Partners II ("Capital Fund II"), RoundTable's second captive subordinated debt fund.  Capital Fund II is a dedicated subordinated debt fund that makes fixed rate subordinated debt investments alongside the equity investments of RoundTable's equity funds. The current shareholders of DPT also acquired a portion of the senior subordinated notes.

About RoundTable Healthcare Partners

RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry.  RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.  RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model.  RoundTable currently manages $1.9 billion in capital, including three equity funds totaling $1.5 billion and two subordinated debt funds totaling $400 million.  More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com.  

About Renaissance Acquisition Holdings

Renaissance Acquisition Holdings (Renaissance), Lake Forest, IL, is a pharmaceutical company formed in partnership with RoundTable Healthcare Partners and Pierre Frechette, the former CEO of Sabex, a previous RoundTable portfolio company.  The mission of Renaissance is to invest in small to mid-size pharmaceutical companies that can benefit from its extensive industry relationships and operational expertise.

About DPT Laboratories

Founded in 1938, DPT Laboratories Inc. is an industry leading contract development and manufacturing organization specializing in semi-solid, liquid and sterile dosage forms. With unmatched technical expertise and fully integrated drug development and manufacturing services for sterile and non-sterile dosage forms, DPT helps its customers successfully develop and commercialize pharmaceutical products. DPT has locations in San Antonio, TX and Lakewood, NJ.  More information about DPT can be found at www.dptlabs.com.


'/>"/>
SOURCE RoundTable Healthcare Partners
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
2. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
3. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
5. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
8. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
9. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ ... Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - ... reach USD 779.8 Million by 2021 from USD 414.6 Million in ... of 2016 to 2021. Continue Reading ... ...
(Date:12/5/2016)... PUNE, India , December 5, 2016 According ... by Product Type and by Application - Global Opportunity Analysis and Industry Forecast, ... 2015, and is expected to reach $5,255 million by 2022, growing at a ... in 2015 with more than four-fifths share. Continue ... ...
(Date:12/5/2016)... and PUNE, India , December ... report by Allied Market Research, titled, "Global Cancer Biomarkers Market ... revenue of cancer biomarkers market is projected to reach $15,737 ... CAGR of 13.3% from 2016 to 2022. Omic technologies segment ... 2015 and is expected to maintain its dominance during the ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... ... For many years, Andrew G. Zubinas has accumulated over 130 hardcover ... Lithuanian language and its poetry inspired him in writing “ Forest Lungs ... aspects of a living, breathing forest where nothing ever stays the same. His subjects ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced today that nominations will be accepted from December 5, 2016 through ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:12/5/2016)... ... December 05, 2016 , ... Worldwise ... global lifestyle design firm kathy ireland® Worldwide for five additional years, announced by ... into an exclusive licensing agreement three years ago to design and develop the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... ICA, ... alerting technology to Central Illinois Health Information Exchange (CIHIE) using its Smart ... as the sole sub-recipient participating with the Illinois Health Information Exchange Authority ...
Breaking Medicine News(10 mins):